Search

Subject 616.992

43. 102P Results from a phase II trial of pembrolizumab (P) plus gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 (PANGEA-Breast) study. (15th December 2019)

Authors:
Merino, L de la Cruz; Cruz, J; Alonso, J L; Garcia, V Quiroga; Anton, F Moreno; Andres, R; Santiesteban, M; Vazquez, M Ramos; Cortes, M Gion; Cortés, J; Carrion, N Palazon; Lenza, I Ceballos; Soto, A; Casas, M; Benito, S; Montes, S Bezares; Holgado, E
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

45. 102PEncyclopedic tumour analysis (ETA) guided combination regimens of hormone receptor antagonists with other systemic agents for treatment of refractory cancers. (7th November 2019)

Authors:
Vaid, A; Crook, T; Ranade, A; Limaye, S; Patil, D; Akolkar, D; Datta, V; Page, R; Schuster, S; Sims, C; Patil, R; Srinivasan, A; Apurwa, S; Datar, R
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 7
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

47. 102PHGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index. (25th November 2018)

Authors:
Suzuki, K; Yuki, S; Nakano, S; Kawamoto, Y; Nakatsumi, H; Hatanaka, K; Ando, T; Furukawa, K; Ishiguro, A; Ohta, T; Eto, K; Nakajima, J; Nakamura, M; Sogabe, S; Kato, K; Tateyama, M; Kato, S; Sekiguchi, M; Sakata, Y; Komatsu, Y
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗